I keep coming back to how confident the wrong advice always sounds. Not tentative, not hedged, but delivered from a podium with the full weight of authority behind it. Skim the fat. Estrogen ruins the aging brain. Lyme doesn’t happen here, so stop asking. A doctor says it, a guideline prints it, and it becomes the thing everyone simply knows, repeated for thirty and forty years until the ticks or the autopsies or the trial data quietly say otherwise.
What has stayed with me this week is not that any single one of these turned out shaky. It is the pattern of the confidence itself, the way certainty gets manufactured and then defended long after the ground has shifted underneath it. Somebody in western North Carolina spent three decades being told their symptoms were in their head, because the map said the disease stopped at the state line.
That is the part I cannot let go of. Real people organize their lives around these pronouncements. They eat differently, take or refuse a drug, dismiss a fever. The least we owe them is to keep asking who benefits when the story stays fixed and the evidence has already moved. So we keep asking.
Autoimmune & Inflammation
Why Anti-TNF Keeps Failing So Many Crohn’s Patients: The Drug Never Reached the Cell Holding the Disease Open
Anti-TNF biologics have muzzled the immune system for 25 years, and up to 46 percent of Crohn’s patients still fail them. A single-cell atlas points at the structural cells of the gut wall, epigenetically rewired into a state the drugs were never built to reach.
One Protein Keeps Your Immune System’s Peacekeeper Cells From Switching Sides
Regulatory T cells are supposed to be the immune system’s off switch. Strip out a protein called TIF1γ and, under inflammation, they lose that identity, start producing an inflammatory cytokine, and join the attack.
Investigations
Eighteen Years and $250 Million Later, Human Limb Regrowth Is Still a Salamander Trick
A Northeastern lab showed exactly how an axolotl rebuilds an arm from the shoulder down, and humans carry the same genes. We can still regrow a lost fingertip as children. Everything past that we heal by scarring over, and $250 million of Pentagon money has not changed the math.
‘No Falsification’: JAMA Keeps a Purdue-Funded Opioid Paper Its Own Retraction Rule Says to Pull
Court records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn’t falsification, so the paper stays in print.
Drugs & FDA
The FDA’s Reviewers Called This Melanoma Data ‘Not Interpretable.’ Nine Days Later, the Agency Approved the Drug.
Twice the FDA rejected Replimune’s engineered-herpes melanoma therapy, its reviewers calling the single-arm trial not interpretable. The design never changed. A 10-3 advisory vote came anyway, and nine days after that memo, the accelerated approval.
NIH Said Its Cervical-Cancer AI Beat Human Doctors. Six Years Later, Its Own Author Called It Overfitting.
In 2019, NIH announced an algorithm that read cervix photos better than doctors, an AUC of 0.91. Its senior author has since written that the number came from overfitting and that the follow-on projects failed. Nature Medicine is now calling the same idea the ‘missing piece.‘
Infectious Disease
For Thirty Years, Doctors Here Were Taught North Carolina Had No Lyme. The Ticks Disagree.
Nearly 40 percent of the adult blacklegged ticks sampled in one western North Carolina town carried the Lyme bacterium, in a state where doctors were trained for thirty years that the disease barely exists.
The FDA Put an Emergency Label on a Zoetis Dog Pill for a Screwworm America Erased in 1966 Without a Single Drug
The sterile-fly barrier that kept the flesh-eating screwworm out of America for sixty years gave way, and Washington’s answer has been a run of emergency drug authorizations, the newest for a Zoetis dog pill whose maker’s own release cites no efficacy data against the parasite.
Metabolic & Weight
A Study Blames the Rising Atmosphere for Your Blood Chemistry. Your Own Breath Overwhelms It.
Blood bicarbonate climbed about 7 percent since 1999, and two researchers blame the rising atmosphere. But convert that 51 ppm into the pressure that reaches your lungs and it moves your blood by about 0.04 millimeters of mercury, roughly a thousand times too small to matter.
Lilly Turned the Receptor On, Amgen Turned It Off, and Both Strip Weight. The Map Came Four Years Late.
Eli Lilly’s tirzepatide switches the gut-hormone receptor on. Amgen’s MariTide blocks it. Both drive weight loss, and until a publicly funded Cambridge mouse study, no one had cleanly mapped how one receptor works in both directions.
Brain & Aging
The Craving Brake Nobody Mapped: How GLP-1 Drugs Quiet Cravings From the Lateral Septum
The anti-craving effect pushing people to use a diabetes shot off-label against drinking traces to a brain region built to inhibit, not to reward, and the human evidence is still just two small trials deep.
For Twenty Years, Women Were Warned That Estrogen Raised Their Dementia Risk. Stanford’s Autopsies Point the Other Way.
A randomized federal trial spent two decades warning that hormone therapy raised older women’s dementia risk. A Stanford autopsy study just found the opposite association. The catch: both studied women who started the drug far too late to settle it.
Nutrition & Food
For Forty Years They Said Skim the Fat. This Trial Fed People Full-Fat Dairy and the Cholesterol Held.
In a 74-adult trial, the group assigned three servings of full-fat dairy a day for twelve weeks held steady on weight, body fat, cholesterol and insulin resistance, and their blood pressure improved, against advice the guidelines have pushed since 1980.